Industry lukewarm on new labelling guidelines

October 31, 2003
Sales and Marketing

New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …

GSK launches prostate drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …

Consultants threaten to quit

October 31, 2003

More than a quarter of hospital consultants are ready to resign or retire from the NHS if they dont receive …

GSK in running for Pfizer incontinence drug

October 31, 2003
Sales and Marketing

GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …

Trusts warned over fixing waiting times

October 31, 2003

All NHS trusts will have to review how they report waiting times after a spot check found widespread distortion and …

Levitra brings three dimensions to ED market

October 31, 2003

Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European …

Staff shortages holding back NHS progress

October 31, 2003

A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to …

BMS attempts to distance itself from fraud allegations

October 31, 2003

Bristol-Myers Squibb is attempting to draw a line under allegations of fraud and financial misconduct by downgrading earnings as far …

Industry reputation under fire at home and abroad

October 31, 2003

Continuing conflict over access to medicines in developing countries and growing distrust of big pharma in domestic markets is threatening …

Germany delay undermines Crestor confidence

October 31, 2003

AstraZeneca's cholesterol treatment Crestor has been dealt a serious blow following Germanys withdrawal from a pan-European approval process.Germany, the EU's …

Parliamentary showdown for foundation trust plans

October 31, 2003

Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …

Smallpox vaccine puts Acambis into profit

October 31, 2003

Vaccine company Acambis has joined rivals PowderJect and Celltech in the elite group of profitable UK biotech companies.The company recorded …

Shire appoints Emmens as new chief executive

October 31, 2003

Matthew Emmens, former head of Merck KGaA's global prescription group, has been appointed as the new Chief Executive of Shire …

Paediatric trials to be mandatory in US

October 31, 2003

Plans to make clinical trials mandatory for all drugs intended for children are progressing in the US.The Paediatric Research Equity …

Savings boost GSK outlook

October 31, 2003

Foundation status offered to 38 more trusts

October 31, 2003

A further 38 hospital have been invited to apply for foundation trust status after winning three stars in the recent …

Doubts over pipeline cloud Aventis results

October 31, 2003

Aventis may struggle to replace revenue from its ageing blockbusters despite a strong performance in the second quarter, according to …

BMS and Lilly exceed expectations

October 31, 2003

Strong sales of established and new products in the second quarter saw both Bristol-Myers Squibb and Eli Lilly beat analysts' …

Smooth transition from old to new for AstraZeneca

October 31, 2003

Growth in new products are helping to plug the sizeable gap left by three of AstraZeneca's ageing blockbusters Prilosec (Losec), …

The Gateway to Local Adoption Series

Latest content